Dr. Massarweh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Palo Alto
Palo Alto, CA 94306Phone+1 650-723-4000- Is this information wrong?
Summary
- I am a medical oncologist and clinician investigator specialized in breast cancer, with a particular focus in hormone receptor positive disease, triple positive breast cancer and breast cancer in men. I have a strong commitment to multidisciplinary and cross functional team development as well as educational leadership as integral parts of my career philosophy.
As part of my philosophy, patient centeredness must the primary driver of value in any healthcare system and the business of medicine must not be given priority over patient well being. Within this concept and as we step outside the box of current healthcare systems, physicians have a responsibility to take more leadership roles in order to restore the core values of the Medical Profession, rather than remain solely as providers or programmatic developers.
Education & Training
Stanford Graduate School of BusinessLEAD Program in Corporate Innovation, LEAD Certificate, 2016 - 2018
Baylor College of MedicineFellowship, Hematology and Medical Oncology, 1999 - 2003- Baylor College of MedicineResidency, Internal Medicine, 1996 - 1999
University of Jordan Faculty of MedicineClass of 1994
Certifications & Licensure
KY State Medical License 2006 - 2025
TX State Medical License 2003 - 2025
CA State Medical License 2014 - 2024- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Intellectual Contribution Award-Crisis Management Stanford Graduate School of Business-LEAD Program in Corporate Innovation, 2020
- Stanford GSB LEAD Certificate Stanford Graduate School of Business, 2018
- National Liklihood To Recommend (LTR) Scores above 90th Percentile 2018
- Join now to see all
Clinical Trials
- Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer Start of enrollment: 2007 Oct 01
- Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure Start of enrollment: 2008 Apr 01
- Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer Start of enrollment: 2014 Nov 20
Publications & Presentations
PubMed
- 45 citationsMolecular Characterization and Mortality From Breast Cancer in Men.Suleiman Massarweh, George W. Sledge, Dave P. Miller, Debbie McCullough, Valentina I. Petkov, Steven Shak> ;Journal of Clinical Oncology. 2018 Mar 27
- 95 citationsUnraveling the mechanisms of endocrine resistance in breast cancer: new therapeutic opportunities.Suleiman Massarweh, Rachel Schiff> ;Clinical Cancer Research. 2007 Apr 1
- 29 citationsImpact of estrogen receptor (ER) and human epidermal growth factor receptor-2 (HER2) co-expression on breast cancer disease characteristics: implications for tumor bio...Abeer Al-Qaisi, Li Chen, Edward H. Romond, Mara D. Chambers, M Stevens, G Pasley, Mukta Awasthi, Suleiman Massarweh> ;Breast Cancer Research and Treatment. 2014 Sep 26
- Join now to see all
Journal Articles
- Inferring breast cancer concomitant diagnosis and comorbidities from the Nationwide Inpatient Sample using social network analysisRadhakrishnan Nagarajan, Shengfan Zhang, Fay Cobb Payton, Suleiman Massarweh, Health Systems, 3/7/2014
- The Role of Ovarian Suppression in the Adjuvant Therapy of Premenopausal Women With ER-Positive Breast Cancer: A Commentary on the EBCTCG Overview AnalysisJames Morgan, MD; Suleiman Massarweh, MD, The American Journal of Hematology/Oncology, 10/2007
Press Mentions
Understanding Male Breast CancerMarch 28th, 2018
Expert Point of View: Suleiman Massarweh, MDFebruary 10th, 2016
Dr. Suleiman Massarweh Discusses His Presentation for Markey Research DayFebruary 4th, 2016- Join now to see all
Committees
- Chair, Cancer Education, Division of Oncology, Stanford University School of Medicine 2015 - 2017
Professional Memberships
- Member
- Member
Other Languages
- Arabic
External Links
- Stanford CAP Profilehttps://med.stanford.edu/profiles/suleiman-massarweh
- Stanford Healthcarehttps://stanfordhealthcare.org/doctors/m/suleiman-massarweh.html
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
